Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Delmer

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Annales De Biologie Clinique|October 23, 2019
Difficult Gram staining: a case of endocarditis due to Cardiobacterium hominis and review of the literatureThomas Blanchot, Anaëlle Muggeo, Anne Limelette, et al.
British Journal of Haematology|December 17, 2003
FcgammaRIIB is differentially expressed during B cell maturation and in B-cell lymphomasSophie Camilleri-Broët, Lydie Cassard, Philippe Broët, et al.
The Analyst|May 29, 2015
Diagnosis approach of chronic lymphocytic leukemia on unstained blood smears using Raman microspectroscopy and supervised classificationTeddy Happillon, Valérie Untereiner, Abdelilah Beljebbar, et al.
British Journal of Haematology|July 25, 2003
Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytesJosée Audouin, Agnès Le Tourneau, Thierry Molina, et al.
Cancers|April 23, 2022
Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA StudyAmélie Lemoine, Marine Perrier, Camille Mazza, et al.
Annals of Hematology|July 5, 2014
Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemiaEdouard Cornet, Alain Delmer, Pierre Feugier, et al.
American Journal of Hematology|November 28, 2014
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)Anne Quinquenel, Christophe Willekens, Jehan Dupuis, et al.
The Lancet. Haematology|March 8, 2016
Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trialSarit Assouline, Valeria Buccheri, Alain Delmer, et al.
British Journal of Haematology|May 7, 2020
Autoimmune haemolytic anaemia associated with COVID-19 infectionGregory Lazarian, Anne Quinquenel, Mathieu Bellal, et al.
Blood|June 22, 2012
CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'AdulteRichard Delarue, Corinne Haioun, Vincent Ribrag, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Annales De Biologie Clinique|October 23, 2019
Difficult Gram staining: a case of endocarditis due to Cardiobacterium hominis and review of the literatureThomas Blanchot, Anaëlle Muggeo, Anne Limelette, et al.
British Journal of Haematology|December 17, 2003
FcgammaRIIB is differentially expressed during B cell maturation and in B-cell lymphomasSophie Camilleri-Broët, Lydie Cassard, Philippe Broët, et al.
The Analyst|May 29, 2015
Diagnosis approach of chronic lymphocytic leukemia on unstained blood smears using Raman microspectroscopy and supervised classificationTeddy Happillon, Valérie Untereiner, Abdelilah Beljebbar, et al.
British Journal of Haematology|July 25, 2003
Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytesJosée Audouin, Agnès Le Tourneau, Thierry Molina, et al.
Cancers|April 23, 2022
Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA StudyAmélie Lemoine, Marine Perrier, Camille Mazza, et al.
Annals of Hematology|July 5, 2014
Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemiaEdouard Cornet, Alain Delmer, Pierre Feugier, et al.
American Journal of Hematology|November 28, 2014
Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)Anne Quinquenel, Christophe Willekens, Jehan Dupuis, et al.
The Lancet. Haematology|March 8, 2016
Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trialSarit Assouline, Valeria Buccheri, Alain Delmer, et al.
British Journal of Haematology|May 7, 2020
Autoimmune haemolytic anaemia associated with COVID-19 infectionGregory Lazarian, Anne Quinquenel, Mathieu Bellal, et al.
Blood|June 22, 2012
CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'AdulteRichard Delarue, Corinne Haioun, Vincent Ribrag, et al.
Pageof 11